News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
GEMMABio and Sahay AI Make Technical.ly Philly’s RealLIST of Up-and-Coming Startups
Technical.ly’s annual RealLIST Startups identifies the top young companies in the Philadelphia region who are on track to continue their momentum.
Every Cure Uses AI Tool to Match Patients with Medications
David Fajgenbaum led a team that developed artificial intelligence powered technology that matches rare diseases with existing medications.
Recently Released Rankings Highlight Penn, PCI, and the Region’s Strong Innovation Performance
Penn, PCI and Philadelphia's growth in innovation are recognized in new reports.
Economic Impact Report Highlights How Penn Helps Drive $37 Billion through the Region’s Economy | Penn Today
Penn released its FY24 Economic Impact Report, which emphasizes how Penn plays a vital role in driving regional economic growth.
2024 Philadelphia Venture Report Recognizes Regional Growth in Venture Funding and Exits as well as Showcasing Thriving Penn Spinouts
The report highlighted the Philadelphia region’s growth in startup exit activity and early-stage investment.
Penn Engineering Welcomes Vanessa Chan as Inaugural Vice Dean of Innovation and Entrepreneurship
Chan brings a wealth of experience in bridging the gap between groundbreaking ideas and real-world impact to her new role at Penn.
Philadelphia’s Biotech Ecosystem Bolstered as WuXi AppTec Deal Eases Congressional Pressure
WuXi AppTec sold its South Philly-based Advanced Therapies contract manufacturing unit to New York-based healthcare investment firm Altaris LLC.
PCI’s John Swartley Nominated as BioBuzz Leader of the Year Finalist
John Swartley, MBA, PhD, Penn’s Chief Innovation Officer, was named as a finalist for BioBuzz Leader of the Year in Greater Philadelphia.
Berger Lab Makes Discovery Linking cellular structures to kidney cancer treatment outcomes
These findings could pave the way for personalized treatments, matching patients to drugs based on their tumor's speckle pattern.
Mitchell Lab Develops a lipid nanoparticle with the potential to deliver an mRNA-based treatment for preeclampsia
The technology addresses a critical health equity gap for pregnant individuals with preeclampsia.